IBM Watson launches medical imaging initiative

When it comes to diagnosing heart disease, IBM Watson is launching its newest feature of its medical imaging initiative to lend a helping hand.

IBM Watson's clinical imaging review will now assess medical data such as images, ultrasounds, x-rays and anything else that is visual and used by medical professionals. The first step of its new move will be to sort out which patients need follow-up care for aortic stenosis (AS).

According to an interview with Mashable, cardiology specialist at Sentara Healthcare Jaime Murillo says, AS is one of the most difficult conditions to diagnose.

With Watson’s new imaging system, professionals will be able to look at an image of a mass and figure out if it’s a tumor, infection or anatomical quirk. They will also be looking at medical records to check for any errors or inconsistencies. If a flag is raised, the system will ask if a patient should come back in. 

Watson Clinical Imaging Review will be the first cognitive imaging offered by IBM.

Read the full story here: 

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Trimed Popup
Trimed Popup